Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8476 to 8490 of 8907 results

  1. HIV testing: increasing uptake in black Africans (PH33)

    This guidance has been updated and replaced by NICE guideline NG60.

    Withdrawn guideline

  2. HIV testing: increasing uptake in men who have sex with men (PH34)

    This guideline has been updated and replaced by NICE guideline NG60.

    Withdrawn guideline

  3. Tuberculosis: identification and management in under-served groups (PH37)

    This guideline has been updated and replaced by NICE guideline NG33.

    Withdrawn guideline

  4. Smokeless tobacco: South Asian communities (PH39)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

    Withdrawn guideline

  5. Substance misuse interventions for vulnerable under 25s (PH4)

    This guidance has been updated and replaced by NICE guideline NG64.

    Withdrawn guideline

  6. Weight management: lifestyle services for overweight or obese adults (PH53)

    This guideline has been updated and replaced by NICE guideline NG246.

    Withdrawn guideline

  7. Alcohol: school-based interventions (PH7)

    This guideline has been updated and replaced by NICE guideline NG135.

    Withdrawn guideline

  8. Physical activity and the environment (PH8)

    This guideline has been updated and replaced by NICE guideline NG90.

    Withdrawn guideline

  9. Community engagement (PH9)

    This guidance has been updated and replaced by NICE guideline NG44.

    Withdrawn guideline

  10. Smoking: workplace interventions (PH5)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

    Withdrawn guideline

  11. UrgoStart for chronic wounds (MIB82)

    This advice has been updated and replaced by NICE medical technologies guidance 42.

    Withdrawn advice

  12. Absorb Bioresorbable Vascular Scaffold system for coronary artery disease (MIB84)

    NICE withdrew this medtech innovation briefing in November 2017 after the company stopped manufacturing Absorb because of low uptake. Some UK hospitals continue to use the technology in ongoing clinical studies.

    Withdrawn advice

  13. COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response (NG172)

    27 May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For people with COVID-19 see our guideline on managing COVID-19. 

    Withdrawn guideline

  14. COVID-19 rapid guideline: children and young people who are immunocompromised (NG174)

    27 May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For children and young people with COVID-19 see our guideline on managing COVID-19. 

    Withdrawn guideline

  15. COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital (NG173)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

    Withdrawn guideline